Anavex Life Sciences Corp (AVXL)

[Investor2014]

Study Type  :	Interventional  (Clinical Trial) 
 Estimated Enrollment  :	100 participants 
 Allocation:	N/A 
 Intervention Model:	Single Group Assignment 
 Masking:	None (Open Label) 
 Primary Purpose:	Treatment 
 Official Title:	Open Label Extension Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001 
 Actual Study Start Date  :	October 10, 2019 
 Estimated Primary Completion Date  :	October 31, 2021 
 Estimated Study Completion Date  :	October 31, 2021

100% eligible is clearly not 100% of trial participants opting for the OLE!!!

If the trial n=150 was in fact 150, not that impressive and n=120 ok.

The actual OLE start date of October 10, 2019 sort of tallies with the Spanish clinical trial site date of November 26, 2019.

As I've posted before big gap between end of trial for many patients and start of OLE.

Which is the correct Primary Completion date September 2020 or the global Spanish completion date of June 11, 2020?

All clear as ditch water.